SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Trading Down 0.8% – What’s Next?

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) shares were down 0.8% on Thursday . The company traded as low as $55.99 and last traded at $56.24. Approximately 127,037 shares were traded during trading, a decline of 11% from the average daily volume of 142,027 shares. The stock had previously closed at $56.68.

SPDR S&P Pharmaceuticals ETF Trading Down 0.8%

The stock has a 50 day simple moving average of $53.94 and a 200-day simple moving average of $48.33. The firm has a market cap of $227.77 million, a PE ratio of 14.28 and a beta of 0.60.

Institutional Trading of SPDR S&P Pharmaceuticals ETF

Several institutional investors and hedge funds have recently added to or reduced their stakes in XPH. Goldman Sachs Group Inc. lifted its holdings in SPDR S&P Pharmaceuticals ETF by 96.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 119,929 shares of the company’s stock worth $5,253,000 after purchasing an additional 59,007 shares in the last quarter. Advantage Trust Co grew its holdings in SPDR S&P Pharmaceuticals ETF by 1,525.0% during the 2nd quarter. Advantage Trust Co now owns 3,250 shares of the company’s stock valued at $132,000 after buying an additional 3,050 shares in the last quarter. Envestnet Portfolio Solutions Inc. raised its position in shares of SPDR S&P Pharmaceuticals ETF by 42.0% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 161,088 shares of the company’s stock valued at $6,537,000 after buying an additional 47,626 shares during the last quarter. SVB Wealth LLC lifted its holdings in shares of SPDR S&P Pharmaceuticals ETF by 1.7% in the third quarter. SVB Wealth LLC now owns 41,689 shares of the company’s stock worth $1,999,000 after buying an additional 677 shares in the last quarter. Finally, Envestnet Asset Management Inc. purchased a new position in shares of SPDR S&P Pharmaceuticals ETF in the third quarter worth $10,732,000.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.